Natera (NTRA) FCF Margin (2014 - 2026)
Natera's (NTRA) quarterly FCF Margin came in at 1.15% in Q2 2026, down 328.0% on a YoY basis from 0.5% in Q2 2025, and down 144.32% quarter-over-quarter from 2.59% in Q1 2026.
Powered by 
Analysis
Natera (NTRA) FCF Margin (2014 - 2026) Analysis & Trends
Natera (NTRA) has reported FCF Margin for 13 consecutive years, with 1.15% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, FCF Margin fell 328.0% year-over-year to 1.15%; the trailing twelve-month figure through Jun 2026 stood at 3.11% (down 221.0% YoY), and the FY2025 full-year result was 4.73%, up 65.0% from the prior year.
- FCF Margin fell to 1.15% in Q2 2026 per NTRA's latest filing, from 2.59% in the prior quarter.
- Across five years, FCF Margin topped out at 8.07% in Q3 2024 and bottomed at 78.9% in Q1 2022.
- Historically, FCF Margin has averaged 17.13% across 5 years, with a median of 1.5% in 2024.
- The sharpest annual moves came in 2022 and 2023: FCF Margin plunged 2300 bps in 2022, then jumped 4064 bps in 2023.
- Over 5 years, FCF Margin stood at 42.79% in 2022, then soared by 49 bps to 21.75% in 2023, then soared by 134 bps to 7.3% in 2024, then fell by 22 bps to 5.68% in 2025, then slumped by 120 bps to 1.15% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 1.15%, 2.59%, and 5.68% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | -1.15% |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 15.08% |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | 8.41% |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | -20.76% |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | -3.57% |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | 2.43% |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | 13.08% |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | 4.65% |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | -10.60% |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | 16.73% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.15% |
| Mar 31, 2026 | 2.59% |
| Dec 31, 2025 | 5.68% |
| Sep 30, 2025 | 6.25% |
| Jun 30, 2025 | 2.14% |
| Mar 31, 2025 | 4.51% |
| Dec 31, 2024 | 7.30% |
| Sep 30, 2024 | 8.07% |
| Jun 30, 2024 | -1.86% |
| Mar 31, 2024 | 1.82% |
| Dec 31, 2023 | -21.75% |
| Sep 30, 2023 | -14.41% |
| Jun 30, 2023 | -33.42% |
| Mar 31, 2023 | -38.26% |
| Dec 31, 2022 | -42.79% |
| Sep 30, 2022 | -54.34% |
| Jun 30, 2022 | -59.85% |
| Mar 31, 2022 | -78.90% |
| Dec 31, 2021 | -62.27% |
| Sep 30, 2021 | -65.90% |